An evaluation of the putative human mammary tumour retrovirus associated with peripheral blood monocytes
1991

Evaluation of Human Mammary Tumour Virus in Blood Monocytes

Sample size: 62 publication Evidence: low

Author Information

Author(s): L.P. Kahl, A.R. Carroll, P. Rhodes, J. Wood, N.G. Read

Primary Institution: Wellcome Research Laboratories

Hypothesis

Is there a human mammary tumour virus associated with blood monocytes in breast cancer patients?

Conclusion

The study found no significant evidence for the presence of a human mammary tumour virus in blood monocytes of breast cancer patients.

Supporting Evidence

  • The study observed no clear-cut difference in multinucleate giant cell formation between breast cancer patients and normal subjects.
  • Statistical analyses showed only marginal differences in MNGC formation.
  • Reverse transcriptase activity was not detected in any of the cultured samples.

Takeaway

The researchers looked for a virus in blood cells from breast cancer patients but didn't find any clear evidence of it.

Methodology

The study involved culturing blood monocytes from breast cancer patients and analyzing multinucleate giant cell formation and reverse transcriptase activity.

Potential Biases

Potential bias due to the small number of subjects and the subjective nature of some analyses.

Limitations

The study had a small sample size and high subject-to-subject variation.

Participant Demographics

24 breast cancer patients, 14 with benign breast disease, and 24 healthy controls, all female, aged 27-75.

Statistical Information

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication